Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C, Gordien E, Rameix-Welti MA, Gault E, Moreau F, Fourati S, Challine D, Pawlotsky JM, Houhou-Fidouh N, Damond F, Mackiewicz V, Charpentier C, Méritet JF, Rozenberg F, Podglajen I, Marot S, Petit H, Burrel S, Akhavan S, Leruez-Ville M, Avettand-Fenoel V, Fourgeaud J, Guilleminot T, Gardiennet E, Bonacorsi S, Carol A, Carcelain G, Villemonteix J, Boukli N, Gozlan J, Morand-Joubert L, Legoff J, Delaugerre C, Chaix ML, Roque-Afonso AM, Dortet L, Naas T, Ronat JB, Lepape S, Marcelin AG, Descamps D.
Vauloup-Fellous C, et al. Among authors: maylin s.
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2235-2241. doi: 10.1007/s10096-021-04232-3. Epub 2021 Mar 29.
Eur J Clin Microbiol Infect Dis. 2021.
PMID: 33782783
Free PMC article.